rs140476054
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP3BP6BS2
The NM_018100.4(EFHC1):c.731G>A(p.Arg244Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00015 in 1,613,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC1 | NM_018100.4 | c.731G>A | p.Arg244Gln | missense_variant | Exon 5 of 11 | ENST00000371068.11 | NP_060570.2 | |
EFHC1 | NM_001172420.2 | c.674G>A | p.Arg225Gln | missense_variant | Exon 6 of 12 | NP_001165891.1 | ||
EFHC1 | NR_033327.2 | n.2057G>A | non_coding_transcript_exon_variant | Exon 4 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152002Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251272Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135826
GnomAD4 exome AF: 0.000153 AC: 223AN: 1461060Hom.: 0 Cov.: 34 AF XY: 0.000129 AC XY: 94AN XY: 726858
GnomAD4 genome AF: 0.000125 AC: 19AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74360
ClinVar
Submissions by phenotype
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Uncertain:1
ClinVar contains an entry for this variant (Variation ID: 205388). This variant has not been reported in the literature in individuals affected with EFHC1-related conditions. This variant is present in population databases (rs140476054, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 244 of the EFHC1 protein (p.Arg244Gln). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EFHC1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
p.Arg244Gln (CGA>CAA): c.731 G>A in exon 5 of the EFHC1 gene (NM_018100.3). The Arg244Gln missense substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The amino acid substitution is non-conservative, as a positively charged Arginine residue is replaced by an uncharged Glutamine residue. Arg244Gln alters a position that is highly conserved across species and in related proteins. This variant lies within the second DM10 domain of the protein, and missense mutations altering nearby codons in this domain have been reported in association with epilepsy (Suzuki et al., 2004; Bai et al., 2009). Multiple in silico models predict Arg244Gln may be damaging to protein structure/function. Based on the available information, Arg244Gln is a candidate for a disease-causing mutation, but the possibility that it is a rare benign variant cannot be excluded. The variant is found in EPILEPSY panel(s). -
Epilepsy, idiopathic generalized, susceptibility to, 7 Benign:1
ACMG/AMP criteria: PP3, BS1, BS4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at